Efficacy and Safety of Hirudotherapy for Improving Sperm Quality Parameters in Male Infertility: A Randomized Controlled Trial
Abtahi-Forooshani MS, Roozbehani S, Fatemi M, Noori A (2026) · Health Science Reports · n=50
Характеристика исследования
- Дизайн
- single-center, parallel-group, open-label randomized controlled trial of hirudotherapy versus no-intervention control in idiopathic male infertility (Fal.C. Islamic Azad University, Isfahan, Iran)
- Размер выборки (n)
- 50
- Вмешательство
- Weekly Hirudo medicinalis leech therapy for 3 months (n=25); semen parameters assessed at baseline and end of intervention
- Компаратор
- No-intervention control group (n=25) with semen parameters assessed at the same time points
- Первичная конечная точка
- Sperm concentration, total sperm count, progressive motility, normal morphology (WHO criteria), sperm DNA fragmentation (TUNEL assay), protamine deficiency (chromomycin A3 staining), and sperm viability/morphology by flow cytometry
- Основной результат
- Sperm concentration increased from 57.7±17.1 to 63.4±13.1 million/mL in the leech arm (p=0.006); total count, progressive motility, and normal morphology all improved significantly vs control (p<0.05); DNA fragmentation decreased by 3.9% in leech arm vs control (p=0.04); protamine deficiency reduced (p=0.02); no adverse events reported
- Длительность наблюдения
- 3 months (12 weekly sessions plus end-of-intervention semen analysis)
- PMID
- 41743152
Ключевые выводы
- First PubMed-indexed RCT of medicinal leech therapy for male infertility sperm quality parameters
- Statistically significant improvement in sperm concentration, motility, morphology, and DNA integrity in the leech arm vs no-treatment control
- DNA fragmentation reduction of ~4% in the leech arm — biologically plausible mechanism via systemic anti-inflammatory and microcirculatory effects
- No reported adverse events across 12 weekly sessions over 3 months
- Iranian Registry of Clinical Trials registration (IRCT20230502058045N) supports transparency
Ограничения
- Small sample (n=50, only 25 per arm) limits subgroup analysis and effect-size precision
- Open-label design with no-intervention control — placebo, expectancy, and lifestyle-change effects cannot be excluded
- Single-center Iranian trial — generalizability to other infertility populations untested
- No pregnancy or live-birth outcomes reported; biomarker-only endpoints
- Mechanism speculative — no measurement of inflammatory markers, oxidative stress, or testicular blood flow to support causal pathway
Клиническое значение
Abtahi-Forooshani 2026 is the first randomized hirudotherapy trial in male infertility and provides preliminary biomarker-level evidence that 12 weekly leech sessions may improve sperm quality parameters in idiopathic infertility. For US clinicians, the trial is investigational only and does not support routine use — male infertility is not among K040187-cleared indications and the open-label design leaves substantial uncertainty. The trial does add an emerging Iranian dimension to the global hirudotherapy evidence base and motivates double-blind sham-controlled replication with downstream fertility outcomes (pregnancy, live birth) before any clinical translation can be considered.
Связанные исследования
The Effectiveness of Leech Therapy in Chronic Low Back Pain
Hohmann CD, Stange R, Steckhan N, Robens S, Ostermann T, Paetow A, Michalsen A (2018)
Hirudotherapy for limb ischemia in the pediatric intensive care unit: a retrospective observational cohort
Resch JC, Hedstrom R, Steiner ME, Said SM, Somani A (2023)
Study of the effect of leeching on plasma endothelin and soluble interleukin-2 receptor in patients with systemic lupus erythematosus
Cheng SP, Liu JL, Yuan J (2005)
Medicinal leech therapy in pain syndromes: a narrative review
Koeppen D, Aurich M, Rampp T (2013)